Abstract

Summary

This systematic review maps the neural and hormonal pathways through which light therapy can simultaneously address sleep disturbance and comorbid depression (SDCD), identifying the lateral habenula (LHb) and suprachiasmatic nucleus (SCN) as a dual-core regulatory system. For lighting designers and clinicians, these findings support the use of targeted light therapy protocols that can address both circadian disruption and mood disorders through shared biological mechanisms.
Abstract

Key Findings

  • The lateral habenula (LHb) and suprachiasmatic nucleus (SCN) form a 'dual-core system' that exerts extensive regulation over both circadian and emotional neural circuits, providing a mechanistic basis for light therapy targeting comorbid sleep and depression disorders.
  • Light-active pathways were identified as modulating multiple hormones (including melatonin and cortisol) whose interactions contribute to alleviating sleep disturbance comorbid depression (SDCD).
  • Neural correlates of SDCD were located by cross-referencing light-responsive circadian circuits with emotional regulation circuits, suggesting overlapping therapeutic targets for light-based interventions.
Categories

Categories

Sleep & Circadian Health: Reviews neural and hormonal pathways by which light therapy alleviates sleep disturbance comorbid with depression, including SCN-mediated circadian regulation.
Mood & Mental Wellness: Examines light-active neural circuits and hormonal interactions relevant to treating depression comorbid with sleep disturbance.
The Science of Light: Identifies the lateral habenula (LHb) and SCN as a 'dual-core system' mediating light therapy effects on circadian and emotional circuits.
Authors

Author(s)

C Yaodong, Y Zhang, G Feng, Y Lei, Q Liu, Y Liu
Publication Date

Publication Year

2023
View more publications